Cargando…

Effectiveness of Empagliflozin With Vitamin D Supplementation in Peripheral Neuropathy in Type 2 Diabetic Patients

Background: Neuropathy is the most prevalent broad-spectrum microvascular complication of diabetes. The present study aims to evaluate the effect of empagliflozin with vitamin D supplementation on diabetic peripheral neuropathy. Methods: A prospective, randomized, controlled study was conducted for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehta, Sanjana, Nain, Parminder, Agrawal, Bimal K, Singh, Rajinder P, Kaur, Jaspreet, Maity, Sabyasachi, Bhattacharjee, Aniruddha, Peela, Jagannadha, Nauhria, Shreya, Nauhria, Samal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Endocrinology/Diabetes/Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730350/ https://www.ncbi.nlm.nih.gov/pubmed/35004028 http://dx.doi.org/10.7759/cureus.20208

Ejemplares similares

Utility of Direct Immunofluorescence in Cutaneous Autoimmune Bullous Disorders
por: Brar, Arika, et al.
Publicado: (2021)

Efficacy of Lanthanum Carbonate and Sevelamer Carbonate as Phosphate Binders in Chronic Kidney Disease—A Comparative Clinical Study
por: Nain, Parminder, et al.
Publicado: (2023)

A Review and Meta-Analysis of the Prevalence and Health Impact of Polycystic Ovary Syndrome Among Medical and Dental Students
por: Coffin, Tamara, et al.
Publicado: (2023)

Academic and Social Impact of Menstrual Disturbances in Female Medical Students: A Systematic Review and Meta-Analysis
por: Maity, Sabyasachi, et al.
Publicado: (2022)

Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Colorectal Carcinoma: A Potential Area of Focus for Future Diagnostics
por: Kaur, Simrandeep, et al.
Publicado: (2022)

Virtual Versus Light Microscopy Usage among Students: A Systematic Review and Meta-Analytic Evidence in Medical Education
por: Maity, Sabyasachi, et al.
Publicado: (2023)

Masked Primary Hyperparathyroidism by Empagliflozin Use
por: Awada, Mariam, et al.
Publicado: (2022)

RF16 | PSUN155 Empagliflozin and the risk of nephrolithiasis
por: Balasubramanian, Priyadarshini, et al.
Publicado: (2022)

THU371 Empagliflozin Associated Pancreatitis: A Case Report
por: Poloju, Alekya, et al.
Publicado: (2023)

Adverse Side Effects: Empagliflozin-Related Acute Pancreatitis Case Report
por: Zeidan, Bassem S, et al.
Publicado: (2020)

ODP192 Empagliflozin associated Euglycemic Diabetic Ketoacidosis and the Terrible Triad
por: Nievera, Karl Homer, et al.
Publicado: (2022)

A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis
por: Fernandez Felix, Daniel A, et al.
Publicado: (2022)

Diabetes Ketoacidosis Complicating as Wrist Drop: A Case Report on Acute Motor Neuropathy
por: Arora, Shreya, et al.
Publicado: (2021)

Post-surgical Euglycemic Diabetic Ketoacidosis in a Patient on Empagliflozin in the Intensive Care Unit
por: Bteich, Fernand, et al.
Publicado: (2019)

PSUN250 Empagliflozin Induced Bladder Cancer in an Adult Patient With Latent Autoimmune Diabetes
por: Alzenaidi, Ahlam, et al.
Publicado: (2022)

Detection of Euglycemic Diabetic Ketoacidosis During Thoracic Surgery 75 Hours After Empagliflozin Discontinuation
por: Nishida, Ai, et al.
Publicado: (2022)

The Role of Vitamin C in Reducing Pain Associated With Diabetic Neuropathy
por: Bai, Amerta, et al.
Publicado: (2021)

Empagliflozin Ameliorates Progression From Prediabetes to Diabetes and Improves Hepatic Lipid Metabolism: A Systematic Review
por: Hossain, Md Fahad, et al.
Publicado: (2022)

Randomized Clinical Trial on Efficacy of Empagliflozin Versus Sitagliptin, In Addition to Metformin in Type 2 Diabetic Patients
por: Mubashir, Muaz, et al.
Publicado: (2022)

SUN-136 Know Your Patients: Our Experience with DKA in the Suburbs
por: Grover, Harshwant, et al.
Publicado: (2019)

The Effect of Empagliflozin on Liver Fat in Type 2 Diabetes Mellitus Patients With Non-Alcoholic Fatty Liver Disease
por: Pokharel, Arbinda, et al.
Publicado: (2021)

SUN-LB030 Empagliflozin Causing Euglycemic Diabetic Ketoacidosis
por: Thomas, Mathew, et al.
Publicado: (2019)

Late Local and Distant Recurrence of Apparently Benign Paraganglioma
por: Singh, Brijesh K, et al.
Publicado: (2022)

A Rare but Life-Threatening Case of Fournier’s Gangrene Caused by Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor, Empagliflozin
por: Jahir, Tahmina, et al.
Publicado: (2022)

A Comparison of the Effects of Empagliflozin and Sitagliptin, When Combined With Metformin, on Lipid Levels in Patients with Type 2 Diabetes: A Clinical Investigation
por: Ahmed, Mazhar, et al.
Publicado: (2023)

COVID-19 and Diabetic Ketoacidosis: Report of Eight Cases
por: Singh, Balraj, et al.
Publicado: (2021)

SAT-LB031 Empagliflozin as an Add-On Medication to Subjects Uncontrolled on DPP4 Inhibitors and Metformin: Real World Data Supporting the Use of Empagliflozin as a Rational Second Add-On in Indian Type 2 Diabetic Patients
por: MS, ANEESH
Publicado: (2019)

COVID-19 and Diabetic Ketoacidosis: A Single Center Experience
por: Singh, Balraj, et al.
Publicado: (2021)

THU260 Development Of Plantar Thermography For Screening Of Diabetic Neuropathy
por: Panamonta, Vipawee, et al.
Publicado: (2023)

Optic Neuropathy Following Acute Decompensated Hypothyroidism (Myxedema Crisis)
por: McBee, Dylan B, et al.
Publicado: (2023)

Determining the role of SGLT2 inhibition with Empagliflozin in the development of diabetic retinopathy
por: Matthews, Jennifer, et al.
Publicado: (2022)

LBSUN162 Cumulative Probability Of Heart Failure Hospitalization Among Non-Hispanic Black Compared To Non-Hispanic White Individuals With Type 2 Diabetes On Empagliflozin (EMPA-AA): Real-world Data
por: Mishriky, Basem M, et al.
Publicado: (2022)

Comparison of the Efficacy of Duloxetine and Pregabalin in Pain Relief Associated with Diabetic Neuropathy
por: Shahid, Wajeeha, et al.
Publicado: (2019)

LBSUN290 A Rare, Sordid Tale Of The Two Most Dreaded Adverse Effects Of SGLT-2 Inhibitors Occurring Concurrently - Acute Pancreatitis And Euglycemic Diabetic Ketoacidosis - Within Days Of Initiating Empagliflozin Therapy.
por: Arora, Gunjan, et al.
Publicado: (2022)

Effect of Alpha-Lipoic Acid in the Treatment of Diabetic Neuropathy: A Systematic Review
por: Abubaker, Saleh A, et al.
Publicado: (2022)

Diabetic Neuropathy: Prevalence and Impact on Quality of Life in Al-Ahsa, Saudi Arabia
por: Alhajji, Arwa M, et al.
Publicado: (2022)

Effect of Ramipril on Cardiac Autonomic Neuropathy in Patients With Type II Diabetes Mellitus
por: Chindhalore, Chaitali A, et al.
Publicado: (2023)

Hyponatremia and Outcome: Is Severity More Important Than Etiology?
por: Singh, Parminder, et al.
Publicado: (2023)

SAT-148 Vitamin B12 Deficiency Among Patients with Metformin and Diabetic Neuropathy.
por: Alvarez, Mauricio, et al.
Publicado: (2019)

MON-645 Association of Baseline Cardio-Metabolic Parameters on the Treatment Effects of Empagliflozin When Added to Metformin in Patients with T2D
por: Inzucchi, Silvio E, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_36qhrcbnuh8bs2lsomcn6htsj3